The global Liposome and Microsphere Delivery System market size is predicted to grow from US$ 5123 million in 2025 to US$ 11040 million in 2031; it is expected to grow at a CAGR of 13.7% from 2025 to 2031.
Liposomes and microspheres are two widely used technologies for drug delivery, each with its own advantages and characteristics. Liposomes are based on phospholipid bilayers and can encapsulate both hydrophilic and hydrophobic drugs, which are highly biocompatible and highly targeted, and are commonly used in cancer therapy, vaccines and anti-infective drugs, but their stability and cost limit their further popularization; microspheres, which are usually made of biodegradable polymers, specialize in long-lasting and controlled release, and are widely used in the treatment of chronic diseases and the delivery of vaccines, but the rate of drug release is greatly affected by the environment. However, the rate of drug release is strongly influenced by the environment. This study will focus on two biotechnologies: liposomes and microspheres.
United States market for Liposome and Microsphere Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Liposome and Microsphere Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Liposome and Microsphere Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Liposome and Microsphere Delivery System players cover Gilead Sciences Ltd, Pacira, Shandong Luye Pharmaceutical Co., Ltd., Sun Pharmaceutical, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淟iposome and Microsphere Delivery System Industry Forecast鈥� looks at past sales and reviews total world Liposome and Microsphere Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Liposome and Microsphere Delivery System sales for 2025 through 2031. With Liposome and Microsphere Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposome and Microsphere Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Liposome and Microsphere Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposome and Microsphere Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Liposome and Microsphere Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposome and Microsphere Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposome and Microsphere Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposome and Microsphere Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Preparation
Segmentation by Application:
Drug Delivery
Vaccine Development
Diagnostic Imaging
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Gilead Sciences Ltd
Pacira
Shandong Luye Pharmaceutical Co., Ltd.
Sun Pharmaceutical
Johnson & Johnson
Leadiant Biosciences (Sigma-Tau)
Ipsen (Onivyde)
Teva Pharmaceutical
Novartis
Lipoid
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
China Pharmaceutical Holding Group Co., Ltd.
Changzhou Jinyuan Pharmaceutical Co., Ltd.
FormuMax Scientific, Inc.
Oakwood Labs
Fuisz Technologies Ltd
Delpharm
Terumois
Powder Systems Limited
PolyMicrospheres
AULBIO
Shanghai Livzon Pharmaceutical Co., Ltd.
Beijing Biote Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Liposome and Microsphere Delivery System market?
What factors are driving Liposome and Microsphere Delivery System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposome and Microsphere Delivery System market opportunities vary by end market size?
How does Liposome and Microsphere Delivery System break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liposome and Microsphere Delivery System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Liposome and Microsphere Delivery System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Liposome and Microsphere Delivery System by Country/Region, 2020, 2024 & 2031
2.2 Liposome and Microsphere Delivery System Segment by Type
2.2.1 Powder
2.2.2 Preparation
2.3 Liposome and Microsphere Delivery System Sales by Type
2.3.1 Global Liposome and Microsphere Delivery System Sales Market Share by Type (2020-2025)
2.3.2 Global Liposome and Microsphere Delivery System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Liposome and Microsphere Delivery System Sale Price by Type (2020-2025)
2.4 Liposome and Microsphere Delivery System Segment by Application
2.4.1 Drug Delivery
2.4.2 Vaccine Development
2.4.3 Diagnostic Imaging
2.5 Liposome and Microsphere Delivery System Sales by Application
2.5.1 Global Liposome and Microsphere Delivery System Sale Market Share by Application (2020-2025)
2.5.2 Global Liposome and Microsphere Delivery System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Liposome and Microsphere Delivery System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Liposome and Microsphere Delivery System Breakdown Data by Company
3.1.1 Global Liposome and Microsphere Delivery System Annual Sales by Company (2020-2025)
3.1.2 Global Liposome and Microsphere Delivery System Sales Market Share by Company (2020-2025)
3.2 Global Liposome and Microsphere Delivery System Annual Revenue by Company (2020-2025)
3.2.1 Global Liposome and Microsphere Delivery System Revenue by Company (2020-2025)
3.2.2 Global Liposome and Microsphere Delivery System Revenue Market Share by Company (2020-2025)
3.3 Global Liposome and Microsphere Delivery System Sale Price by Company
3.4 Key Manufacturers Liposome and Microsphere Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposome and Microsphere Delivery System Product Location Distribution
3.4.2 Players Liposome and Microsphere Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Liposome and Microsphere Delivery System by Geographic Region
4.1 World Historic Liposome and Microsphere Delivery System Market Size by Geographic Region (2020-2025)
4.1.1 Global Liposome and Microsphere Delivery System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Liposome and Microsphere Delivery System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Liposome and Microsphere Delivery System Market Size by Country/Region (2020-2025)
4.2.1 Global Liposome and Microsphere Delivery System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Liposome and Microsphere Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liposome and Microsphere Delivery System Sales Growth
4.4 APAC Liposome and Microsphere Delivery System Sales Growth
4.5 Europe Liposome and Microsphere Delivery System Sales Growth
4.6 Middle East & Africa Liposome and Microsphere Delivery System Sales Growth
5 Americas
5.1 Americas Liposome and Microsphere Delivery System Sales by Country
5.1.1 Americas Liposome and Microsphere Delivery System Sales by Country (2020-2025)
5.1.2 Americas Liposome and Microsphere Delivery System Revenue by Country (2020-2025)
5.2 Americas Liposome and Microsphere Delivery System Sales by Type (2020-2025)
5.3 Americas Liposome and Microsphere Delivery System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposome and Microsphere Delivery System Sales by Region
6.1.1 APAC Liposome and Microsphere Delivery System Sales by Region (2020-2025)
6.1.2 APAC Liposome and Microsphere Delivery System Revenue by Region (2020-2025)
6.2 APAC Liposome and Microsphere Delivery System Sales by Type (2020-2025)
6.3 APAC Liposome and Microsphere Delivery System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Liposome and Microsphere Delivery System by Country
7.1.1 Europe Liposome and Microsphere Delivery System Sales by Country (2020-2025)
7.1.2 Europe Liposome and Microsphere Delivery System Revenue by Country (2020-2025)
7.2 Europe Liposome and Microsphere Delivery System Sales by Type (2020-2025)
7.3 Europe Liposome and Microsphere Delivery System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liposome and Microsphere Delivery System by Country
8.1.1 Middle East & Africa Liposome and Microsphere Delivery System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Liposome and Microsphere Delivery System Revenue by Country (2020-2025)
8.2 Middle East & Africa Liposome and Microsphere Delivery System Sales by Type (2020-2025)
8.3 Middle East & Africa Liposome and Microsphere Delivery System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposome and Microsphere Delivery System
10.3 Manufacturing Process Analysis of Liposome and Microsphere Delivery System
10.4 Industry Chain Structure of Liposome and Microsphere Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposome and Microsphere Delivery System Distributors
11.3 Liposome and Microsphere Delivery System Customer
12 World Forecast Review for Liposome and Microsphere Delivery System by Geographic Region
12.1 Global Liposome and Microsphere Delivery System Market Size Forecast by Region
12.1.1 Global Liposome and Microsphere Delivery System Forecast by Region (2026-2031)
12.1.2 Global Liposome and Microsphere Delivery System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Liposome and Microsphere Delivery System Forecast by Type (2026-2031)
12.7 Global Liposome and Microsphere Delivery System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Gilead Sciences Ltd
13.1.1 Gilead Sciences Ltd Company Information
13.1.2 Gilead Sciences Ltd Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.1.3 Gilead Sciences Ltd Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Gilead Sciences Ltd Main Business Overview
13.1.5 Gilead Sciences Ltd Latest Developments
13.2 Pacira
13.2.1 Pacira Company Information
13.2.2 Pacira Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.2.3 Pacira Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pacira Main Business Overview
13.2.5 Pacira Latest Developments
13.3 Shandong Luye Pharmaceutical Co., Ltd.
13.3.1 Shandong Luye Pharmaceutical Co., Ltd. Company Information
13.3.2 Shandong Luye Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.3.3 Shandong Luye Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shandong Luye Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Shandong Luye Pharmaceutical Co., Ltd. Latest Developments
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Information
13.4.2 Sun Pharmaceutical Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sun Pharmaceutical Main Business Overview
13.4.5 Sun Pharmaceutical Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.5.3 Johnson & Johnson Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Leadiant Biosciences (Sigma-Tau)
13.6.1 Leadiant Biosciences (Sigma-Tau) Company Information
13.6.2 Leadiant Biosciences (Sigma-Tau) Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.6.3 Leadiant Biosciences (Sigma-Tau) Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Leadiant Biosciences (Sigma-Tau) Main Business Overview
13.6.5 Leadiant Biosciences (Sigma-Tau) Latest Developments
13.7 Ipsen (Onivyde)
13.7.1 Ipsen (Onivyde) Company Information
13.7.2 Ipsen (Onivyde) Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.7.3 Ipsen (Onivyde) Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ipsen (Onivyde) Main Business Overview
13.7.5 Ipsen (Onivyde) Latest Developments
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Information
13.8.2 Teva Pharmaceutical Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Teva Pharmaceutical Main Business Overview
13.8.5 Teva Pharmaceutical Latest Developments
13.9 Novartis
13.9.1 Novartis Company Information
13.9.2 Novartis Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.9.3 Novartis Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Novartis Main Business Overview
13.9.5 Novartis Latest Developments
13.10 Lipoid
13.10.1 Lipoid Company Information
13.10.2 Lipoid Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.10.3 Lipoid Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Lipoid Main Business Overview
13.10.5 Lipoid Latest Developments
13.11 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
13.11.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Company Information
13.11.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.11.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Latest Developments
13.12 Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
13.12.1 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Company Information
13.12.2 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.12.3 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Latest Developments
13.13 China Pharmaceutical Holding Group Co., Ltd.
13.13.1 China Pharmaceutical Holding Group Co., Ltd. Company Information
13.13.2 China Pharmaceutical Holding Group Co., Ltd. Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.13.3 China Pharmaceutical Holding Group Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 China Pharmaceutical Holding Group Co., Ltd. Main Business Overview
13.13.5 China Pharmaceutical Holding Group Co., Ltd. Latest Developments
13.14 Changzhou Jinyuan Pharmaceutical Co., Ltd.
13.14.1 Changzhou Jinyuan Pharmaceutical Co., Ltd. Company Information
13.14.2 Changzhou Jinyuan Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.14.3 Changzhou Jinyuan Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Changzhou Jinyuan Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Changzhou Jinyuan Pharmaceutical Co., Ltd. Latest Developments
13.15 FormuMax Scientific, Inc.
13.15.1 FormuMax Scientific, Inc. Company Information
13.15.2 FormuMax Scientific, Inc. Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.15.3 FormuMax Scientific, Inc. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 FormuMax Scientific, Inc. Main Business Overview
13.15.5 FormuMax Scientific, Inc. Latest Developments
13.16 Oakwood Labs
13.16.1 Oakwood Labs Company Information
13.16.2 Oakwood Labs Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.16.3 Oakwood Labs Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Oakwood Labs Main Business Overview
13.16.5 Oakwood Labs Latest Developments
13.17 Fuisz Technologies Ltd
13.17.1 Fuisz Technologies Ltd Company Information
13.17.2 Fuisz Technologies Ltd Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.17.3 Fuisz Technologies Ltd Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Fuisz Technologies Ltd Main Business Overview
13.17.5 Fuisz Technologies Ltd Latest Developments
13.18 Delpharm
13.18.1 Delpharm Company Information
13.18.2 Delpharm Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.18.3 Delpharm Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Delpharm Main Business Overview
13.18.5 Delpharm Latest Developments
13.19 Terumois
13.19.1 Terumois Company Information
13.19.2 Terumois Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.19.3 Terumois Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Terumois Main Business Overview
13.19.5 Terumois Latest Developments
13.20 Powder Systems Limited
13.20.1 Powder Systems Limited Company Information
13.20.2 Powder Systems Limited Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.20.3 Powder Systems Limited Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Powder Systems Limited Main Business Overview
13.20.5 Powder Systems Limited Latest Developments
13.21 PolyMicrospheres
13.21.1 PolyMicrospheres Company Information
13.21.2 PolyMicrospheres Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.21.3 PolyMicrospheres Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 PolyMicrospheres Main Business Overview
13.21.5 PolyMicrospheres Latest Developments
13.22 AULBIO
13.22.1 AULBIO Company Information
13.22.2 AULBIO Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.22.3 AULBIO Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 AULBIO Main Business Overview
13.22.5 AULBIO Latest Developments
13.23 Shanghai Livzon Pharmaceutical Co., Ltd.
13.23.1 Shanghai Livzon Pharmaceutical Co., Ltd. Company Information
13.23.2 Shanghai Livzon Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.23.3 Shanghai Livzon Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Shanghai Livzon Pharmaceutical Co., Ltd. Main Business Overview
13.23.5 Shanghai Livzon Pharmaceutical Co., Ltd. Latest Developments
13.24 Beijing Biote Pharmaceutical Co., Ltd.
13.24.1 Beijing Biote Pharmaceutical Co., Ltd. Company Information
13.24.2 Beijing Biote Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Portfolios and Specifications
13.24.3 Beijing Biote Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Beijing Biote Pharmaceutical Co., Ltd. Main Business Overview
13.24.5 Beijing Biote Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
